(Q39874088)

15 September 2017

Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer (English)

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

17 December 2022

1 reference

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

17 December 2022

3

S. E. Salmon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A153787

17 December 2022

author name string

R. E. Lloyd

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A153787

17 December 2022

S. E. Jones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A153787

17 December 2022

language of work or name

English

0 references

publication date

1 January 1979

1 reference

full work available at URL

15 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

17 December 2022

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

17 December 2022

1 reference

15 September 2017

43

1 reference

15 September 2017

1

1 reference

15 September 2017

60-65

1 reference

An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy

15 September 2017

1

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer

17 December 2022

3

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

17 December 2022

5

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.

17 December 2022

7

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

17 December 2022

Cancer Treatment Reports

8

60

1463

Heuson

1976

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

17 December 2022

9

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Nonparametric Estimation from Incomplete Observations

17 December 2022

10

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Oestrogen receptors in breast cancer: a changing concept

17 December 2022

11

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer

17 December 2022

12

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Ovarian function in patients receiving adjuvant chemotherapy for breast cancer

17 December 2022

13

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

17 December 2022

Cancer Treatment Reports

14

60

1451

Tormey

1976

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

Perspectives in the treatment of breast cancer: 1976

17 December 2022

15

1 reference

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C60::AID-CNCR2820430108%3E3.0.CO;2-M

17 December 2022

Identifiers

10.1002/1097-0142(197901)43:1<60::AID-CNCR2820430108>3.0.CO;2-M

1 reference

15 September 2017

1 reference